Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Japan Lifeline CoFRA:L8B -0.66%85 Return-on-Tangible-Asset is 13.19% as of Mar. 2026, which is 14% above its 10-year median of 11.52. GuruFocus rates FRA:L8B with a GF Score™ of 85/100 and a GF Value™ of €8.00. The stock has 1 warning sign investors should review. Among 854 Medical Devices & Instruments companies, Japan Lifeline Co ranks better than 88.64% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Japan Lifeline Co's annualizedNet Income for the quarter that ended in Mar. 2026 was €55.1 Mil. Japan Lifeline Co's average total tangible assets for the quarter that ended in Mar. 2026 was €418.2 Mil. Therefore, Japan Lifeline Co's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 13.19%.
The historical rank and industry rank for Japan Lifeline Co's Return-on-Tangible-Asset or its related term are showing as below:
FRA:L8B'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 2.72 Med: 11.52 Max: 14.91
Current: 12.66
During the past 13 years, Japan Lifeline Co's highest Return-on-Tangible-Asset was 14.91%. The lowest was 2.72%. And the median was 11.52%.
FRA:L8B's Return-on-Tangible-Asset is ranked better than 88.64% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 0.665
vs FRA:L8B: 12.66
Japan Lifeline Co (FRA:L8B) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Japan Lifeline Co Return-on-Tangible-Asset Related Terms
Japan Lifeline Co Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Japan Lifeline Co's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:L8B vs ABT, SYK, MDT: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, Japan Lifeline Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Lifeline Co Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Japan Lifeline Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Japan Lifeline Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 13.19% mean?
Japan Lifeline Co (FRA:L8B) has a Return-on-Tangible-Asset of 13.19% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Japan Lifeline Co and its competitors. This is 14% above median its historical median of 11.52. Over the past decade, Japan Lifeline Co's Return-on-Tangible-Asset has ranged from 2.72 to 14.91. According to the industry distribution chart, Japan Lifeline Co ranks #97 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 11.4%.
Is Japan Lifeline Co's Return-on-Tangible-Asset too high?
Japan Lifeline Co's current Return-on-Tangible-Asset of 13.19% is 14% above median its 10-year median of 11.52. Over the past 10 years, this metric has ranged from a low of 2.72 to a high of 14.91. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.67. Japan Lifeline Co's value of 13.19% is 1883.5% above this industry median. Based on the distribution chart, Japan Lifeline Co ranks #97 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Japan Lifeline Co has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Japan Lifeline Co's Return-on-Tangible-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Japan Lifeline Co ranks #97 out of 854 companies for Return-on-Tangible-Asset. This places Japan Lifeline Co in the top 11% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.67. Japan Lifeline Co's value of 13.19% is 1883.5% above this benchmark. Historically, Japan Lifeline Co's own Return-on-Tangible-Asset has ranged from 2.72 to 14.91 over the past decade. While the company's 10-year median is 11.52 vs. the industry median of 0.67, Japan Lifeline Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.67, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Japan Lifeline Co's current Return-on-Tangible-Asset of 13.19% is 1883.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Japan Lifeline Co and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Lifeline Co's current Return-on-Tangible-Asset is 13.19%, which is 14% above median its own 10-year median of 11.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Lifeline Co stock overvalued right now?
Japan Lifeline Co (FRA:L8B) has a current Return-on-Tangible-Asset of 13.19%. The stock's GF Value™ is €8.00, compared to a current price of €7.55 — trading 5.6% below its estimated fair value. The current Return-on-Tangible-Asset is 13.19%, which is 14% above median its 10-year median of 11.52 and 1883.5% above the Medical Devices & Instruments industry median of 0.67. Japan Lifeline Co's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Japan Lifeline Co (FRA:L8B), the current Return-on-Tangible-Asset is 13.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Lifeline Co (FRA:L8B) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Lifeline Co stock appears to be undervalued.
The current stock price of €7.55 is trading 5.6% below its estimated GF Value™ of €8.00.
Key valuation signals for FRA:L8B:
Return-on-Tangible-Asset: 13.19% (14% above median its 10-year median of 11.52)
GF Value™: €8.00 vs. price of €7.55 (5.6% below fair value)
Industry Position: 1883.5% above the Medical Devices & Instruments median (#97 of 854)
No single metric tells the full story. See the FRA:L8B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Lifeline Co Ltd is a medical device company operating in Japan. It is engaged in the trading and manufacturing of medical devices specialized in the cardiovascular field. The company offers medical devices mainly for the treatment of cardiac and vascular diseases. It focuses on providing implantable devices to treat arrhythmias; disposable catheter devices with electrodes for diagnosis and treatment of arrhythmias; prosthetic devices to replace blood vessels and heart valves that lost their functions; and devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities and congenital cardiac diseases.
85GF Score
Get the complete analysis for FRA:L8B
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L8B has been successfully added to your 
